Your browser doesn't support javascript.
loading
Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia.
Day, Daphne; Grech, Lisa; Nguyen, Mike; Bain, Nathan; Kwok, Alastair; Harris, Sam; Chau, Hieu; Chan, Bryan; Blennerhassett, Richard; Nott, Louise; Hamad, Nada; Tognela, Annette; Hoffman, David; McCartney, Amelia; Webber, Kate; Wong, Jennifer; Underhill, Craig; Sillars, Brett; Winkel, Antony; Savage, Mark; Loe, Bao Sheng; Freeman, Daniel; Segelov, Eva.
Afiliación
  • Day D; Department of Oncology, Monash Health, Clayton, VIC 3168, Australia.
  • Grech L; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.
  • Nguyen M; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.
  • Bain N; Department of Oncology, Monash Health, Clayton, VIC 3168, Australia.
  • Kwok A; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.
  • Harris S; Department of Oncology, Monash Health, Clayton, VIC 3168, Australia.
  • Chau H; Department of Oncology, Monash Health, Clayton, VIC 3168, Australia.
  • Chan B; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.
  • Blennerhassett R; Department of Medical Oncology, Bendigo Health, Bendigo, VIC 3550, Australia.
  • Nott L; Department of Oncology, Latrobe Regional Hospital, Traralgon, VIC 3844, Australia.
  • Hamad N; Department of Oncology, Sunshine Coast Hospital and Health Service, Birtinya, QLD 4575, Australia.
  • Tognela A; School of Medicine, Griffith University, Birtinya, QLD 4575, Australia.
  • Hoffman D; Central Coast Haematology, North Gosford, NSW 2250, Australia.
  • McCartney A; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW 2308, Australia.
  • Webber K; Icon Cancer Centre Hobart, Hobart, TAS 7000, Australia.
  • Wong J; Department of Haematology, St Vincent's Hospital Sydney, Darlinghurst, NSW 2010, Australia.
  • Underhill C; School of Clinical Medicine, Faculty of Medicine & Health, University of New South Wales, Kensington, NSW 2052, Australia.
  • Sillars B; School of Medicine, University of Notre Dame Australia, Chippendale, NSW 2007, Australia.
  • Winkel A; Macarthur Cancer Therapy Centre, Campbelltown Hospital, Campbelltown, NSW 2560, Australia.
  • Savage M; Dr David Hoffman, Fairfield, NSW 2165, Australia.
  • Loe BS; Department of Oncology, Monash Health, Clayton, VIC 3168, Australia.
  • Freeman D; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.
  • Segelov E; Department of Oncology, Monash Health, Clayton, VIC 3168, Australia.
  • On Behalf Of The Canvaccs Diabvaccs And Msvaccs Investigators; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.
Vaccines (Basel) ; 10(6)2022 May 26.
Article en En | MEDLINE | ID: mdl-35746458
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Australia